English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 5 October 2023, 08:52 HKT/SGT
Share:
    

Source: CorDx
CorDx to Launch New Global Brand, CuPet, in Singapore

SINGAPORE, Oct 5, 2023 - (ACN Newswire) - CorDx will take a revolutionary step in animal healthcare with the official global launch of CuPet at the 2023 Singapore Vet Show. CuPet aims to be customers' first choice in animal health, offering a one-stop solution for all diagnostic needs.

CuPet will showcase its innovative solutions at the Singapore Vet Show at booth D12 from October 13-14, 2023.

With an unwavering dedication to animal well-being, CuPet delivers accurate, intuitive, and affordable diagnostic test kits. Focused on efficiency and speed, CuPet diagnostic tests are designed for both veterinarians and pet owners. The brand prioritizes precise disease identification, ensuring quick and reliable results when every second counts. CuPet's comprehensive product range offers solutions for a variety of species and diseases, eliminating the need for multiple suppliers.

Developed through rigorous research, CuPet adheres to the highest scientific standards. The brand's product line includes 13 CE-marked test kits, employing advanced technologies such as colloidal gold and PCR. CuPet ensures user-friendly design, enabling both professionals and first-time pet owners to trust their intuitive solutions.

CuPet doesn't just provide products; it offers unparalleled customer support. From training to assistance, CuPet ensures that every user maximizes the utility and reliability of its products.

With a focus on affordability, CuPet challenges the market with competitive pricing without compromising on quality.

For More Information:

To view CuPet's product range or request a demo, visit en.cupet.com.

About CorDx :

Headquartered in the United States, CorDx is transforming the global diagnostics industry with innovative R&D solutions, a vertically integrated supply chain, and manufacturing footprints across the United States and around the world. Through its product realization partnerships with leading pharmaceutical companies, CorDx develops, manufactures, and distributes diagnostics and related tools that empower users to monitor and improve their health. Its proprietary line of diagnostics solutions is recognized by families and medical professionals for their reliability, affordability, and rapid results.

CorDx, a CorDx Union company, is a biotechnology organization that delivers medical device solutions to healthcare industries and over a billion users in more than 170 countries.

Contact Information

Jessica Wills, Marketing Director, cupet@cordx.com, (678) 6802380



Topic: Press release summary
Source: CorDx

Sectors: Regional
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
International Women's Day: Why Menopause May Be a Missed Cardiovascular Risk Window  
Friday, March 6, 2026 7:00:00 PM
Xunce (3317.HK) Released Profit Alert: Revenue Doubles, Surpasses Expectations by a Wide Margin, China's Palantir Rises!  
Mar 6, 2026 18:23 HKT/SGT
Hong Kong Completes First Green Methanol Bunkering, Driving Green Transformation of Its International Shipping Hub  
Mar 6, 2026 15:05 HKT/SGT
Hong Kong Tech Innovators Drive Success at Mobile World Congress and 4YFN Barcelona 2026  
Mar 6, 2026 13:08 HKT/SGT
U.S. Polo Assn. Expands Collegiate Partnership Program to Record 70 Teams for 2026 Season  
Mar 6, 2026 12:12 HKT/SGT
Anime Tokyo Station: "That Time I Got Reincarnated as a Slime" Special Exhibition, February 21 to May 24, 2026  
Mar 6, 2026 10:00 HKT/SGT
TANAKA Develops World's First High-Performance Palladium Hydrogen Permeable Membrane Exhibiting High Hydrogen Purification Performance at Temperatures around 100 degrees C  
Thursday, March 5, 2026 9:00:00 PM
Lancaster Resources Announces Resignation of Penny White and the Addition of Rob Heaslop to the Board of Directors  
Mar 5, 2026 17:29 HKT/SGT
CMS (867.HK/8A8.SG): Self-Developed INHBE-Targeting siRNA Drug Received IND Approval for Overweight/Obesity  
Mar 5, 2026 16:00 HKT/SGT
Honda to Begin Sales of Two U.S.-built Vehicles in Japan  
Thursday, March 5, 2026 3:47:00 PM
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575